Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMBUYIK)

Drug Name
CWP232291 Drug Info
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 1/2 [1]
Multiple myeloma 2A83 Phase 1 [2]
Cross-matching ID
TTD Drug ID
DMBUYIK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Wnt signaling pathway (Wnt pathway)
Drug Name Drug ID Indication ICD 11 Highest Status REF
SM04554 DM30JWZ Alopecia ED70 Phase 2/3 [3]
SM-04690 DMOLTAD Osteoarthritis FA00-FA05 Phase 2 [4]
SM08502 DM4KLNA Solid tumour/cancer 2A00-2F9Z Phase 1 [2]
SM04755 DM491NI Liver cancer 2C12 Phase 1 [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Wnt signaling pathway (Wnt pathway) TTFPSHI NOUNIPROTAC Inhibitor [2]

References

1 ClinicalTrials.gov (NCT03055286) Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 Clinical pipeline report, company report or official report of Phrma.org Arthritis 2014.
5 A Phase 1, Open-Label, Dose-Escalation, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of SM04755 in Subjects with Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer.